Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework

Research Policy

Volumn 41, Issue 2, 2012, Pages 430-441

  Guennif, Samira ^a   Ramani, Shyama V ^b  

^a UNIVERSITÉ PARIS 13   (France)

^b UNU MERIT   (Netherlands)

Author keywords

Brazil; Catch up; India; Industrial capabilities; National system of innovation; Pharmaceutical industry

Indexed keywords

BRAZIL; CATCH-UP; INDIA; INDUSTRIAL CAPABILITIES; NATIONAL SYSTEM OF INNOVATION; PHARMACEUTICAL INDUSTRY;

INTELLECTUAL PROPERTY; LAWS AND LEGISLATION;

INDUSTRY;

EID: 84855919270     PISSN: 00487333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.respol.2011.09.005     Document Type: Article

References (68)

1. M. Abramovitz Catching-up, forging and falling behind The Journal of Economic History 46 2 1986 385 406
2. H. Ahmad Technological Development in Drugs and Pharmaceutical Industry in India 1988 Navrang New Delhi
3. M. Andréa-Loyola Sida, Santé Publique Et Politique Du Medicament Au Brésil/Autonomie Ou Dependence Sciences sociales et santé 27 3 2009 47 74
4. S. Athreye, D. Kale, and S.V. Ramani Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector Industrial and Corporate Change 18 4 2009 729 759
5. J.A.Z. Bermudez Remedio: Saude Ou Industria? A Produao De Medicamentos No Brasil 1992 Relume Dumara Rio de Janeiro
6. J.A.Z. Bermudez, and M.A. Oliveira Intellectual Property in the Context of the Wto Trips Agreement 2004 WHO/PAHO Collaborating Center for Pharmaceutical Policies National School of Public Health Sergio Arouca and Oswaldo Cruz Foundation Rio de Janeiro
7. M. Cassier, and M. Correa Scaling up and reverse-engineering: acquisition of industrial knowedge by copying drugs in Brazil B. Coriat, The Political Economy of HIV/Aids in Developing Countries: Trips, Public Health Systems and Free Access 2008 Edward Elgar Cheltenham, UK
8. A. Chadha Trips and patenting activity: evidence from the Indian pharmaceutical industry Economic Modelling 26 2 2009 499 505
9. Chaturvedi, S.; Dynamics of biotechnology research and industry in India, in: OECD Science, Technology and Industry Working Papers, 2005/2006.
10. K. Chaturvedi, J. Chattaway, and D. Wield Policy, markets and knowledge: strategic synergies in Indian pharmaceutical firms Technology Analysis and Strategic Management 19 5 2007 565 589
11. S. Chaturvedi Exploring interlinkages between national and sectoral innovation systems for rapid technologica catch-up: case of Indian biopharmaceutical industry Technology Analysis and Strategic Management 19 5 2007 643 659
12. Chaudhuri, S.; 2007. Is product patent protection necessary in developing countries for innovation? R&D by Indian Pharmaceutical Companies after Trips, Indian Institute of Management Calcutta. Working Paper Series: WPS No. 614/September 2007, Calcutta.
13. S. Chaudhuri The Wto and India's Pharmaceuticals Industry 2005 Oxford University Press New Delhi
14. R. Chittoor, S. Ray, P.S. Aulakh, and M.B. Sarkar Strategic responses to institutional changes: 'indigenous growth' model of the Indian pharmaceutical industry Journal of International Management 14 2008 252 269
15. C.L. da Silva, and A. Oliviera Brazilian industry policy after 1990: focussing on the pharmaceutical industry Journal of Technology Management and Innovation 2 3 2007 71 84
16. L.X. De Lemos Capanema A Industria Farmaceutica Brasileira E a Atuaao Do Bndes 2006 BNDES Sectorial Rio de Janeiro
17. Edquist, C.; 2001. The systems of innovation approach and innovation policy: an account of the state of the art. Lead Paper Presented at the DRUID Conference, June 12-15, Aalborg.
18. C. Edquist Systems of Innovation: Technologies 1997 Institutions and Organizations Pinter, London
19. J. Fagerberg Innovation, Catching-up and Growth, International Seminar on Science, Technology and Economic Growth 1989 OECD Paris 5-8 June
20. S. Feinberg, and S.K. Majumdar Technology spillovers from foreign direct investment in the Indian pharmaceutical industry Journal of International Business Studies 32 3 2001 421 437 (Pubitemid 33583086)
21. B. Fialho, L. Hasenclever, and J.M.C. Mello The Geography of Innovation in the Pharmaceutical Industry: Assessing Implications for Developing Countries, In Connecting People, Ideas and Resources across Communities D. Gibson, M. Heitor, A. Ibarra, International series on technology policy and innovation 2004 Purdue University Press
22. C. Freeman The national system of innovation in historical perspective Cambridge Journal of Economics 19 1995 5 24
23. J. Frenkel O Mercado Farmacêutico Brasileiro: a Sua Evoluão Recente, Mercados E Preos B. Negri, G. Di Giovani, Brasil: Radiografia Da Saúde 2001 IE/Unicamp Campinas
24. J. Frenkel, J.N. Reis, J.T. Araújo, L.C. Naidin, R.S. Lobão, and M.S. Fonseca Tecnologia e Competião na Indústria Farmacêutica Brasileira 1978 FINEP/CEP/GEPETEC Rio de Janeiro
25. Frischtak, C.R.; 1989. The protection of intellectual property rights and industrial technology development in Brazil. The World Bank, Industrial and Energy Department, Working Paper, Industry Series Washington, DC.
26. Gehl-Sampath, P.; 2006. Indian pharma within global reach? UNU-Merit Working Paper, 2006-031. United Nations University, Maastricht.
27. P. Gehl-Sampath India's Pharmaceutical Sector in 2008: Emerging Strategies and Global and Local Implications for Access to Medicines 2008 Department for International Development (DFID) London
28. Greene, W.; 2007. The emergence of India's pharmaceutical industry and implications for the U.S. generic drug market. Office of Economics Working Paper, U.S. International Trade Commission. Washington, DC.
29. Guennif, S.; 2004. Aids in India: public health related aspects of industrial policy and intellectual property rights in a developing country. CSH Occasional Paper 8, Centre de Sciences Humaines, Publication of the French Research Institutes in India, Rajdhani Art Press.
30. D. Kale, and S. Little From imitation to innovation: the evolution of R&D capabilities and learning processes in the Indian pharmaceutical industry Technology Analysis and Strategic Management 19 5 2007 589 611
31. D. Kale, and D. Wield Exploitative and explorative learning as a response to the trips agreement in Indian pharmaceutical firms Industry and Innovation 15 1 2008 93 114
32. S. Lall International pharmaceutical industry and less-developed countries Economic and Political Weekly 1974 1990 1996
33. S. Lall The international pharmaceutical industry and less-developed countries, with special reference to India Oxford Bulletin of Economics and Statistics 36 3 1974 143 172
34. D. Landes The Wealth and Poverty of Nations 1998 Abacus London
35. K. Lee, and C. Lim Technological regimes, catching-up and leapfrogging: findings from the Korean industries Research Policy 30 2001 459 483 (Pubitemid 33674596)
36. B.A. Lundvall Why study national systems and national styles of innovation? Technology Analysis and Strategic Management 10 4 1998 407 421
37. B.A.E. Lundvall National Innovation Systems: Towards a Theory of Innovation and Interactive Learning 1992 Pinter London
38. F. Malerba Sectoral systems of innovation and production Research Policy 31 2 2002 247 264
39. R. Marques, and C.G. Neto The Brazilian system of innovation in biotechnology: a preliminary study Journal of Technology Management and Innovation 2 1 2007 55 63
40. A. Nassif National innovation system and macroeconomic policies: Brazil and India in comparative perspective United Nations Conference on Trade and Development 2007
41. R. Nelson Economic development from the perspective of evolutionary economic theory Oxford Development Studies 36 1 2008 9 21
42. R. Nelson National Innovation Systems: A Comparative Analysis 1993 Oxford University Press Oxford
43. R.R. Nelson, and S.G. Winter An evolutionary Theory of economic Change 1982 Harvard University Press
44. Oliveira, M.A.; Bermudez, J.A.Z.; Epsztejn, R.; Costa Chaves, G.; Ferreira, R.L.; Oliveira, M.T.; 2004. Pharmaceutical patent protection in Brazil: who is benefiting. In: Bermudez, J.A.Z.; Oliveira, M.A. (Eds.), Intellectual Property in the Context of the Wto Trips Agreement. WHO/PAHO Collaborating Center for Pharmaceutical Policies, National School of Public Health Sergio Arouca and Oswaldo Cruz Foundation, Rio de Janeiro.
45. OPPI Organisation of Pharmaceutical Producers of India 2001, 2004 Pharmaceutical Compendium Mumbai
46. Orsi, F.; Hasenclever, L.; Fialho, B.; Tigre, P.; Coriat, B.; 2003. Intellectual property rights, anti-aids policy and generic drugs: lessons from the Brazilian public health program. In: Moatti, J.P.; Coriat, B.; Souteyrand, Y.; Barnett, T.; Dumoulin, J.; Flori, Y.A. (Eds.), Economics of Aids and Access to Hiv/Aids Care: Issues and Challenges. Edition de l'Agence Nationale de Recherches sur le Sida, Paris.
47. E.T. Penrose The Theory of the Growth of the Firm 1959 John Wiley New York
48. Queiroz, S.R.R.; 1993. Os Determinantes Da Capacitaao Tecnologica No Sector Quimico-Farmaceutico Brasileiro. Ph.D. Thesis, Department of Economics. UNICAMP.
49. S.R.R. Queiroz Un Transfert Réussi Et Contrarié Par Une Politique De Développement National: La Production Pharmaceutique C. Durand, La Coopération Internationale Et Les Transferts De Technologie 1994 De Boeck Brussels
50. S.V. Ramani, and A. Maria Trips and its possible impact on the biotech based segment of the Indian pharmaceutical industry Economic and Political Weekly February 2005 675 683 (Pubitemid 40358751)
51. S.V. Ramani Who's interested in biotechnology: R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms Research Policy 31 2002 381 398
52. S.V. Ramani, and M.S. Venkataramani Rising to the technological challenge: integration of biotechnology in the Indian pharmaceutical industry International Journal of Biotechnology 3 1/2 2001 95 115 (Pubitemid 32610056)
53. Robine, A.; 2008. Transfert Et Acquisition De La Technologie Dans Les Pays Émergents: L'exemple Brésilien De L'accs Aux Médicaments Contre Le Sida. Ph.D. Thesis, Department of Economics. Université Paris 1 Panthéon-Sorbonne.
54. R. Romano, and P. Bernardo Padrões De Regulaão De Preos Do Mercado De Medicamentos: Experiência Brasileira Dos Anos 90 E Novos Arranjos Institucionais B. Negri, G. Di Giovani, Brasil: Radiografia Da Saúde 2001 IE/Unicamp Campinas
55. M. Ryan Patent incentives, technology markets and public-private bio-medical innovation networks in Brazil World Development 38 8 2010 1082 1093
56. K. Shadlen The politics of patents and drugs in Brazil and Mexico: the industrial bases of health policies Comparative Politics 42 1 2009 41 58
57. R. Simonetti, E. Archambault, G. Cote, and D. Kale The dynamics of pharmaceutical patenting in India: evidence from USPTO data Technology Analysis and Strategic Management 19 5 2007 625 642 (Pubitemid 47393880)
58. S. Singh Multinational Corporations and Indian Drug Industry 1985 Criterion Publications New Delhi
59. L. Soete International diffusion of technology, industrial development and technological leapfrogging World Development 13 3 1985 409 422
60. S. Srinivasan Battling patent laws: the Glivec case Economic and Political Weekly 2007 3686 3691
61. W. Suzigan, and J. Furtado Industrial policy and development CEPAL Review 2006
62. C. Sweet Regulating the tigers: the institutional dynamics of Indo-Brazilian Trade reflections from the pharmaceutical sector ELSNIT Conference on Institutional Dimensions of Integration and Trade Barcelona 2007
63. D.J. Teece, G. Pisano, and A. Shuen Dynamic capabilities and strategic management Strategic Management Journal 18 1997 509 533 (Pubitemid 127467809)
64. H. Thorsteinsdóttir, C.C. Melon, M. Ray, S. Chakkalackal, M. Li, J.E. Cooper, J. Chadder, T.W. Saenz, M. Carlota, and P. de Souza South-South entrepreneurial collaboration in health biotech Nature Biotechnology 28 2010 407 416
65. Tribune des droits de l'homme, 2007. L'industrie Indienne N'aide Pas Les Indiens. http://www.humanrights-geneva.info/article.php3?id-article=2152.
66. E. Urias, and J. Furtado Institutional Changes and Their Impacts on the Brazilian Pharmaceutical Industry 2009 Globelics Dakar
67. B. Waning, E. Diedrichsen, and S. Moon A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries Journal of the International AIDS Society 13 35 2010 1 10
68. WHO, 2010. Who List of Prequalified Medicinal Products, World Health Organization. Available from: http://who.int/prequal/ (accessed October 2010).